Clinical trial
Association of Plasma Thrombospondin-4 Levels and Peripheral Arterial Disease in Hemodialysis Patients
NCT04735562 is registered in ClinicalTrials.gov with Tungs' Taichung Metroharbour Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Association of Plasma Thrombospondin-4 Levels and Peripheral Arterial Disease in Hemodialysis Patients
- Lead sponsor
- Tungs' Taichung Metroharbour Hospital
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 1, 2021
- Completion date
- December 31, 2021
- Enrollment
- 280 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.